SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-22-067113
Filing Date
2022-10-28
Accepted
2022-10-28 15:11:50
Documents
4
Period of Report
2022-12-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT def14a0422_inmedpharm.htm DEF 14A 1555631
2 GRAPHIC tinmed_logo.jpg GRAPHIC 114164
3 GRAPHIC tproxy_001.jpg GRAPHIC 1254791
4 GRAPHIC tproxy_002.jpg GRAPHIC 1120391
  Complete submission text file 0001213900-22-067113.txt   4986135
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-39685 | Film No.: 221341286
SIC: 2834 Pharmaceutical Preparations